Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

High-risk corneal allografts and why they lose their immune privilege.

Niederkorn JY.

Curr Opin Allergy Clin Immunol. 2010 Oct;10(5):493-7. doi: 10.1097/ACI.0b013e32833dfa11. Review.

2.

Immune privilege of corneal allografts.

Niederkorn JY, Larkin DF.

Ocul Immunol Inflamm. 2010 Jun;18(3):162-71. doi: 10.3109/09273948.2010.486100. Review.

3.

Allergic conjunctivitis renders CD4(+) T cells resistant to t regulatory cells and exacerbates corneal allograft rejection.

Reyes NJ, Chen PW, Niederkorn JY.

Am J Transplant. 2013 May;13(5):1181-92. doi: 10.1111/ajt.12198. Epub 2013 Mar 13.

4.

Allergic airway hyperreactivity increases the risk for corneal allograft rejection.

Niederkorn JY, Chen PW, Mellon J, Stevens C, Mayhew E.

Am J Transplant. 2009 May;9(5):1017-26. doi: 10.1111/j.1600-6143.2009.02603.x.

5.

Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.

Sano Y, Ksander BR, Streilein JW.

Invest Ophthalmol Vis Sci. 1995 Oct;36(11):2176-85.

PMID:
7558710
6.

In vitro-expanded CD4(+)CD25(high)Foxp3(+) regulatory T cells controls corneal allograft rejection.

Guo X, Jie Y, Ren D, Zeng H, Zhang Y, He Y, Pan Z.

Hum Immunol. 2012 Nov;73(11):1061-7. doi: 10.1016/j.humimm.2012.08.014. Epub 2012 Aug 29.

PMID:
22939904
7.

Foxp3-expressing sensitized Teff cells prolong survival of corneal allograft in corneal allograft transplantation mouse model.

Zhao J, Li Z, Wang L, Liu J, Wang D, Chen G, Wang Q, Zhang H.

Transpl Immunol. 2015 Nov;33(3):192-7. doi: 10.1016/j.trim.2015.09.003. Epub 2015 Sep 28.

PMID:
26419203
8.

Tolerogenic dendritic cells suppress murine corneal allograft rejection by modulating CD28/CTLA-4 expression on regulatory T cells.

Yan F, Cai L, Hui Y, Chen S, Meng H, Huang Z.

Cell Biol Int. 2014 Jul;38(7):835-48. doi: 10.1002/cbin.10268. Epub 2014 Mar 14.

PMID:
24604878
9.

Effect of rapamycin and interleukin-2 on regulatory CD4+CD25+Foxp3+ T cells in mice after allogenic corneal transplantation.

Wang X, Wang W, Xu J, Le Q.

Transplant Proc. 2013 Mar;45(2):528-37. doi: 10.1016/j.transproceed.2012.06.064. Epub 2012 Sep 13.

PMID:
23267787
10.

The immune privilege of corneal allografts.

Niederkorn JY.

Transplantation. 1999 Jun 27;67(12):1503-8. Review.

PMID:
10401754
11.

T cell subsets in the immune rejection of murine heterotopic corneal allografts.

Matoba AY, Peeler JS, Niederkorn JY.

Invest Ophthalmol Vis Sci. 1986 Aug;27(8):1244-54.

PMID:
2942516
12.

New thoughts on the immunology of corneal transplantation.

Streilein JW.

Eye (Lond). 2003 Nov;17(8):943-8.

PMID:
14631401
13.

Severing corneal nerves in one eye induces sympathetic loss of immune privilege and promotes rejection of future corneal allografts placed in either eye.

Paunicka KJ, Mellon J, Robertson D, Petroll M, Brown JR, Niederkorn JY.

Am J Transplant. 2015 Jun;15(6):1490-501. doi: 10.1111/ajt.13240. Epub 2015 Apr 14.

14.

Role of donor-specific cytotoxic T cells in rejection of corneal allografts in normal and high-risk eyes.

Ksander BR, Sano Y, Streilein JW.

Transpl Immunol. 1996 Mar;4(1):49-52.

PMID:
8762010
15.

Immunogenicity and immune privilege of corneal allografts.

Hori J, Niederkorn JY.

Chem Immunol Allergy. 2007;92:290-9. Review.

PMID:
17264504
16.

Two different regulatory T cell populations that promote corneal allograft survival.

Cunnusamy K, Paunicka K, Reyes N, Yang W, Chen PW, Niederkorn JY.

Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6566-74. doi: 10.1167/iovs.10-6161. Epub 2010 Aug 11.

17.

IL-17A-dependent CD4+CD25+ regulatory T cells promote immune privilege of corneal allografts.

Cunnusamy K, Chen PW, Niederkorn JY.

J Immunol. 2011 Jun 15;186(12):6737-45. doi: 10.4049/jimmunol.1100101. Epub 2011 May 6.

18.

The immunogenic privilege of corneal allografts.

Niederkorn JY, Peeler JS, Ross J, Callanan D.

Reg Immunol. 1989 Mar-Apr;2(2):117-24. Review.

PMID:
2701814
19.

Immunological disruption of antiangiogenic signals by recruited allospecific T cells leads to corneal allograft rejection.

Tan Y, Cruz-Guilloty F, Medina-Mendez CA, Cutrufello NJ, Martinez RE, Urbieta M, Wilson D, Li Y, Perez VL.

J Immunol. 2012 Jun 15;188(12):5962-9. doi: 10.4049/jimmunol.1103216. Epub 2012 May 16.

20.

Infiltrating Foxp3(+) regulatory T cells from spontaneously tolerant kidney allografts demonstrate donor-specific tolerance.

Hu M, Wang C, Zhang GY, Saito M, Wang YM, Fernandez MA, Wang Y, Wu H, Hawthorne WJ, Jones C, O'Connell PJ, Sparwasser T, Bishop GA, Sharland AF, Alexander SI.

Am J Transplant. 2013 Nov;13(11):2819-30. doi: 10.1111/ajt.12445. Epub 2013 Sep 18.

Supplemental Content

Support Center